Primary staging and follow-up in melanoma patients - Monocenter evaluation of methods, costs and patient survival

British Journal of Cancer

Volumn 87, Issue 2, 2002, Pages 151-157

  Hofmann, U ^a   Szedlak, M ^a   Rittgen, W ^b   Jung, E G ^a   Schadendorf, D ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Follow up; Health economy; Malignant melanoma; Prognosis

Indexed keywords

ANAMNESIS; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHOGRAPHY; FOLLOW UP; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MELANOMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

ABDOMINAL NEOPLASMS; BONE NEOPLASMS; COHORT STUDIES; COST-BENEFIT ANALYSIS; DIAGNOSTIC TESTS, ROUTINE; FEMALE; GERMANY; HEALTH CARE COSTS; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MELANOMA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PHYSICAL EXAMINATION; RADIOGRAPHY, THORACIC; RADIONUCLIDE IMAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 0037100876     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600428     Document Type: Article

References (36)

1. Stage I-II melanoma: The value of metastatic work-up
2. Cost-effectiveness surveillance of stage I melanoma
3. Usefulness of paraclinical follow-up in stage I melanoma
4. Follow-up in stage I cutaneous malignant melanoma: An audit
5. Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during follow-up of patients with cutaneous melanoma
6. Diagnosis and treatment of early melanoma
7. A rational approach to melanoma follow-up in patients with primary cutaneous melanoma
8. Nachbeobachtung von patienten mit einem melanom im stadium I nach exzision des primärtumors: Einfach und kosteneffizient
9. The multidisciplinary melanoma clinic: A cost outcomes analysis of specialty care
10. Data on first recurrence after treatment for malignant melanoma in a large patient population
11. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: A multicenter randomized controlled trial
12. Malignant melanoma: Which examinations are useful in staging and follow up?
13. Melanoma follow-up: Protocols and practice
14. Laboratory tests and imaging studies in patients with cutaneous malignant melanoma
15. The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma
16. Evaluation of staging workup in malignant melanoma
17. A prospective randomized study of follow-up after radical surgery for colorectal cancer
18. Impact on survival by method of recurrence detection in stage I and II cutaneous melanoma
19. Life-long screening of patients with intermediate-thickness cutaneous melanoma for asymptomatic pulmonary recurrences
20. Which type of follow-up?
21. Stellungnahme und empfehlungen der kommission malignes melanom der Deutschen dermatologischen gesellschaft zur diagnostik, behandlung und nachsorge des malignen melanoms der haut
22. Follow-up recommendations for patients with American Joint Committee on Cancer stages I-III malignant melanoma
23. Laboratory tests and imaging studies in patients with cutaneous malignant melanoma: A survey of experienced physicians
24. Lymphatic mapping and sentinel lymphadenectomy
25. Follow-up recommendations for patients with stage I malignant melanoma
26. Follow-up of colorectal cancer - A meta-analysis
27. Staging evaluation and surveillance for melanoma patients in a fiscally restrictive medical environment
28. Intensive diagnostic follow-up after treatment for primary breast cancer: A randomized trail
29. Consensus on the management of melanoma of the skin in the Netherlands
30. Melanoma recurrance surveillance. Patient or physician based?
31. Factors affecting survival following local, regional or distant recurrence from localized melanoma
32. Use of chest radiography in the initial evaluation of patients with localized melanoma
33. Ultrasonographic evaluation of superficial lymph node metastases in melanoma
34. An estimate of the annual direct cost of treating cutaneous melanoma
35. Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas
36. Metastatic disease in patients with newly diagnosed malignant melanoma